Tradestie Institutional Equity Comparison Engine

PTN vs ATOS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATOS Overall Edge

ATOS Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Atossa Therapeutics, Inc. Common Stock (ATOS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PTN trades at 42.9x Forward P/E with -65.7% operating margin (-80.1% YoY revenue) versus ATOS at 7.0x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ATOS sits in BREAKDOWN (37th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ATOS
PTN 42.9x vs ATOS 7.0x Fwd P/E
Growth & Margin Winner ATOS
Op Margin -65.7% vs 0.0% ยท YoY -80.1% vs +0.0%
Momentum & Technical Winner ATOS
1Y -43.3% vs +140.4% ยท 52W Pos 6% vs 20%
Options & Structure Winner ATOS
UNCLASSIFIED (N/A IV) vs BREAKDOWN (37th %ile IV)
PTN US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap $11.1M
1M Return +1.74%
1Y Return -43.29%
Forward P/E 42.9x
Unified AI Score
31.5 / 100 SELL
Tech 15.0 Fund 30.0 Flow 50.0 Mom 40.0
ATOS NASDAQ
Atossa Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$1.93
-1.53% 1D
Market Cap $19.6M
1M Return -33.68%
1Y Return +140.44%
Forward P/E 7.0x
Unified AI Score
59.2 / 100 HOLD
Tech 70.0 Fund 65.0 Flow 64.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PTN -43.29% ATOS +140.44% Spread: +183.73 pp (ATOS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PTN Revenue ATOS Revenue PTN Op. Margin ATOS Op. Margin Margin Edge
FY2017 $70M N/A 38.6% N/A PTN
FY2018 $70M N/A 38.6% N/A PTN
FY2019 $60M N/A 59.3% N/A PTN
FY2020 $0M N/A -20007.6% N/A PTN
FY2022 $0M N/A -2491.6% N/A PTN
FY2023 $0M N/A -668.7% N/A PTN
FY2024 $0M N/A -501.0% N/A PTN
FY2026 $10M N/A -65.7% N/A PTN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PTN (0) vs ATOS (9)
Institutional Metric PTN ATOS Criterion Row Winner
Market Capitalization Scale $11.1M $19.6M Larger Scale Tie
Trailing P/E Ratio Valuation 42.9x 7.0x Lower Multiple ATOS
Forward P/E Ratio Valuation 42.9x 7.0x Lower Multiple ATOS
Revenue Growth (YoY) Growth -80.1% +0.0% Higher Growth ATOS
Operating Margin (TTM) Profitability -65.7% 0.0% Higher Margin ATOS
Net Profit Margin Profitability -63.5% 0.0% Higher Margin ATOS
Return on Equity (ROE) Capital Efficiency -877.5% -96.9% Higher ROE ATOS
52-Week Range Position Momentum 6% ($5โ€“$31) 20% ($1โ€“$8) Stronger Trend ATOS
Beta / 30D Volatility Risk Regime 0.87ฮฒ ยท 106% Vol 0.35ฮฒ ยท 67% Vol Lower Realized Risk ATOS
Unified Institutional Score Composite Signal 31.5 / 100 (SELL) 59.2 / 100 (HOLD) Higher Composite ATOS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PTN vs ATOS Buy Guide
PTN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PTN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATOS BREAKDOWN
64d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATOS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PTN nor ATOS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.